[go: up one dir, main page]

ATE280584T1 - Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe - Google Patents

Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe

Info

Publication number
ATE280584T1
ATE280584T1 AT00931158T AT00931158T ATE280584T1 AT E280584 T1 ATE280584 T1 AT E280584T1 AT 00931158 T AT00931158 T AT 00931158T AT 00931158 T AT00931158 T AT 00931158T AT E280584 T1 ATE280584 T1 AT E280584T1
Authority
AT
Austria
Prior art keywords
ewing
treatment
eoe
sarcoma
produce
Prior art date
Application number
AT00931158T
Other languages
English (en)
Inventor
Josiane Sanceau
Jeanne Wietzerbin
Original Assignee
Inst Nat Sante Rech Med
Inst Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Inst Curie filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE280584T1 publication Critical patent/ATE280584T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00931158T 1999-04-09 2000-04-10 Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe ATE280584T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904480A FR2791894B1 (fr) 1999-04-09 1999-04-09 Utilisation d'interferon beta dans le traitement de la tumeur d'ewing
PCT/EP2000/004171 WO2000061172A1 (en) 1999-04-09 2000-04-10 Interferon-beta use in the treatment of ewing's family of tumors

Publications (1)

Publication Number Publication Date
ATE280584T1 true ATE280584T1 (de) 2004-11-15

Family

ID=9544241

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00931158T ATE280584T1 (de) 1999-04-09 2000-04-10 Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe

Country Status (9)

Country Link
US (1) US6749846B1 (de)
EP (1) EP1165117B1 (de)
AT (1) ATE280584T1 (de)
AU (1) AU4918900A (de)
CA (1) CA2369427C (de)
DE (1) DE60015306T2 (de)
ES (1) ES2234605T3 (de)
FR (1) FR2791894B1 (de)
WO (1) WO2000061172A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20030130A0 (fi) * 2003-01-29 2003-01-29 Licentia Oy Seulontamenetelmä

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
EP0783891B1 (de) * 1995-07-25 2006-12-27 Toray Industries, Inc. Interferon-beta gegen knochenerkrankungen

Also Published As

Publication number Publication date
CA2369427A1 (en) 2000-10-19
CA2369427C (en) 2011-01-04
AU4918900A (en) 2000-11-14
EP1165117A1 (de) 2002-01-02
WO2000061172A1 (en) 2000-10-19
FR2791894A1 (fr) 2000-10-13
US6749846B1 (en) 2004-06-15
ES2234605T3 (es) 2005-07-01
DE60015306T2 (de) 2006-03-02
EP1165117B1 (de) 2004-10-27
DE60015306D1 (de) 2004-12-02
FR2791894B1 (fr) 2001-07-13

Similar Documents

Publication Publication Date Title
DE69533112D1 (de) Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
DE69333321D1 (de) Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.
DE69914463D1 (en) Therapeutische chemokine rezeptor antagonisten
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
ATE209908T1 (de) RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
DE69636343D1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
BG101118A (en) Therapeutical compounds
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
KR910005858A (ko) 지방산 요법
ATE230609T1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
DE69130063D1 (de) Antivirales arzneimittel enthaltend prostratin
RU2003100517A (ru) Новый интерферон для лечения рассеянного склероза
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
ATE280584T1 (de) Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
DE69233773D1 (de) Verwendung von topotecan zur herstellung eines medikaments zur verwendung in der behandlung von ovarialkrebs
ES2183977T3 (es) Combinacion de temozolomida y alfa-interferon para el tratamiento de cancer avanzado.
ATE335494T1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE60020550D1 (de) Methode und mittel zur behandlung eines post-poliosyndroms
GEP20012366B (en) Thienyl-, Furil-, Pyrrolyl- and Biphenyl-Sulfonamides, Their Derivatives, Their Use in Medicinal Purposes, Pharmaceutical Composition Containing the Same and Method for Treatment

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties